NPI: 1376104125 · AURORA, CO 80011 · Dental Clinic/Center · NPI assigned 06/24/2019
Authorized official MICHAEL, LINDA controls 20+ related entities in our dataset. Read more
| Authorized Official | MICHAEL, LINDA (VP, CHIEF COMPLIANCE OFFICER) |
| Parent Organization | CHILDREN'S HOSPITAL COLORADO |
| NPI Enumeration Date | 06/24/2019 |
Other providers sharing the same authorized official: MICHAEL, LINDA
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 25,147 | $553K |
| 2020 | 59,996 | $1.80M |
| 2021 | 58,174 | $1.75M |
| 2022 | 62,858 | $1.24M |
| 2023 | 48,117 | $1.02M |
| 2024 | 44,699 | $1.01M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 52,527 | 47,294 | $2.05M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 5,493 | 5,237 | $920K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 4,218 | 1,523 | $877K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 17,348 | 6,731 | $861K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 21,530 | 19,607 | $503K |
| 92609 | 2,460 | 948 | $350K | |
| 92551 | 8,384 | 7,211 | $310K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 9,413 | 3,577 | $286K |
| 81025 | 6,669 | 5,908 | $161K | |
| 92526 | 933 | 388 | $131K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 771 | 658 | $110K |
| 92523 | 421 | 371 | $102K | |
| 97535 | Self-care/home management training, each 15 minutes | 817 | 378 | $57K |
| 96125 | 94 | 43 | $52K | |
| 97161 | 1,079 | 887 | $47K | |
| 91300 | 2,506 | 2,131 | $39K | |
| 91307 | 1,881 | 1,708 | $38K | |
| 97760 | 751 | 481 | $36K | |
| 36415 | Collection of venous blood by venipuncture | 7,522 | 5,652 | $30K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 129,560 | 116,965 | $29K |
| 0001A | 1,260 | 1,202 | $29K | |
| 99188 | 235 | 232 | $28K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 197 | 178 | $28K |
| 0072A | 796 | 794 | $27K | |
| 0071A | 945 | 923 | $26K | |
| 0002A | 971 | 932 | $23K | |
| 92508 | Group treatment of speech, language, voice, communication, and/or auditory processing disorder | 362 | 103 | $21K |
| 90791 | Psychiatric diagnostic evaluation | 30 | 26 | $20K |
| 90837 | Psychotherapy, 53 minutes with patient | 168 | 90 | $19K |
| 90686 | 797 | 629 | $17K | |
| 92587 | 719 | 652 | $17K | |
| 90474 | 1,301 | 1,240 | $15K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1,199 | 576 | $12K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 319 | 291 | $11K |
| 97166 | 82 | 72 | $9K | |
| 91305 | 349 | 340 | $8K | |
| 0003A | 273 | 262 | $7K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,000 | 502 | $7K |
| 0053A | 177 | 170 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 147 | 136 | $6K |
| 90480 | 192 | 189 | $6K | |
| 0154A | 113 | 113 | $5K | |
| 92002 | 29 | 29 | $5K | |
| 36416 | 2,307 | 1,953 | $4K | |
| 90656 | 130 | 130 | $4K | |
| 91308 | 126 | 122 | $3K | |
| 91315 | 113 | 113 | $3K | |
| 0051A | 83 | 83 | $3K | |
| 90834 | Psychotherapy, 45 minutes with patient | 37 | 17 | $3K |
| 20560 | 85 | 60 | $3K | |
| 0124A | 58 | 58 | $3K | |
| 77073 | 25 | 25 | $2K | |
| 0173A | 51 | 51 | $2K | |
| 91312 | 58 | 58 | $2K | |
| 92579 | 220 | 192 | $2K | |
| 0082A | 40 | 40 | $1K | |
| 91317 | 51 | 51 | $1K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 60 | 49 | $1K |
| 0083A | 27 | 27 | $1K | |
| 0052A | 28 | 28 | $1K | |
| 20561 | 45 | 24 | $997.19 | |
| 92567 | 1,117 | 1,007 | $724.93 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 971 | 856 | $75.21 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 103 | 85 | $68.31 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 971 | 856 | $65.21 |
| 82728 | 48 | 47 | $64.17 | |
| 80061 | Lipid panel | 208 | 186 | $52.44 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 133 | 91 | $0.00 |
| V5264 | Ear mold/insert, not disposable, any type | 65 | 56 | $0.00 |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 38 | 26 | $0.00 |
| 85027 | 39 | 26 | $0.00 | |
| 92556 | 17 | 17 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 42 | 41 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 44 | 44 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 26 | 25 | $0.00 |
| 85018 | 55 | 53 | $0.00 | |
| V5275 | Ear impression, each | 42 | 42 | $0.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 90 | 90 | $0.00 |
| 99215 | Prolong outpt/office vis | 4,226 | 3,251 | $0.00 |
| 92582 | 152 | 148 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 26 | 25 | $0.00 |
| 92555 | 86 | 82 | $0.00 | |
| 83655 | 73 | 71 | $0.00 | |
| V5011 | Fitting/orientation/checking of hearing aid | 71 | 66 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 299 | 260 | $0.00 |
| V5266 | Battery for use in hearing device | 47 | 47 | $0.00 |
| 92552 | 14 | 14 | $0.00 | |
| 99201 | 356 | 321 | $0.00 | |
| 97799 | 20 | 15 | $0.00 | |
| 84460 | 18 | 18 | $0.00 | |
| 92557 | 12 | 12 | $0.00 |